Yahoo Web Search

  1. Ads
    related to Leukemia
  1. Bristol-Myers' (BMY) Q3 Earnings & Revenues Beat Estimates

    Zacks via Yahoo FinanceOct 31 15:37 PM

    Bristol-Myers Squibb Company BMY reported better-than-expected results for the third quarter of 2019 on stellar performance of its blood thinner drug, Eliquis. Shares were down in pre-market ...

  2. AbbVie Inc. ABBV is scheduled to report third-quarter 2019 results on Nov 1, before market opens. In the last reported quarter, AbbVie delivered a positive earnings surprise of 2.26%. Shares ...

  3. Revenues increased year-over-year, driven by a strong uptake of Tibsovo in the frontline and relapsed/refractory acute myeloid leukemia (AML) settings. Agios’ first wholly owned drug ...

  4. NASDAQ: MRKR) OpGen Inc (NASDAQ: OPGN) (announced a common stock offering) Orgenesis Inc (NASDAQ: ORGS) Precision BioSciences Inc (NASDAQ: DTIL) Selecta Biosciences Inc (NASDAQ: SELB) TRACON ...

  5. AbbVie Inc’s ABBV flagship product, Humira, has witnessed declining sales in the past couple of quarters given the launch of biosimilars in international markets, especially Europe. These launches ...

  6. Alzheimer's Drug May Resurrect Biogen's Growth

    GuruFocus.com via Yahoo FinanceOct 25 22:23 PM

    This past Tuesday, Biogen Inc. (NASDAQ:BIIB) announced it has changed its outlook regarding its trial-phase Alzheimer's drug aducanumab in light of new test results. Biogen is a pharmaceutical ...

  7. Here's a roundup of top developments in the biotech space over the last 24 hours. AstraZeneca plc (NYSE: AZN) (reacted to a beat-and-raise quarter) Edwards Lifesciences Corp (NYSE: EW)( reported ...

  8. U.S. drugmaker Bristol-Myers Squibb Co reported higher-than-expected third-quarter profit on Thursday, helped by strong sales of blood thinner Eliquis, even as growth of its blockbuster cancer ...

  9. Earnings, clinical trial readouts and positive FDA verdicts catalyzed fairly robust performances by biotech stocks last week. Biogen Inc (NASDAQ: BIIB )'s about-face with respect to its Alzheimer's drug ...

  10. Today, the National Comprehensive Cancer Network® (NCCN ®) published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Hematopoietic Cell Transplantation (HCT), also ...

  1. Ads
    related to Leukemia